Related to Takeda Inks $13.6B Deal to Buy Nycomed to Bolster Footprint in Europe and Emerging Markets

• Obesity Therapies Show Lackluster Efficacy Results
  A potential market of $10 billion annually in the U.S. alone is keeping companies in the race to develop better drugs.
  
• Asia-Pacific’s March toward a New Drug Development Paradigm
  Increasing investment, embracing new R&D models, and aligning regulatory agencies are key to the region’s success.
  
• Innovations in Peptide Structure Pushing Candidates through Development
  Companies are taking aim at otherwise untractable targets.
  
• Reporting from J.P. Morgan on Tool and Service Providers
  2011 is expected to be the year of recovery.
  
• High-Tech Companies Buy Into Biomanufacturing
  Samsung and Fujifilm believe such high-investment diversification will help business.
  
• Asia’s Emerging Markets Catching Up to the U.S. and Europe in Terms of Innovation
  Countries like China and Korea are growing to be more than just manufacturing hubs.
  
• India’s Biotechnology Future—As Easy as R&D, as Challenging as China
  Success depends on fortifying country’s research sector through internal programs and global collaborations.
  
• U.S. Stem Cell Companies Find Partners and Revenues Beyond the Water’s Edge
  Firms find it easier to navigate regulatory requirements in Asia as well as Europe.
  
• For Some Emerging Companies, the Road to Growth Connects the U.S. and China
  While American firms are tapping China’s size and regulatory path, Chinese biotechs are going west for money and expertise.
  
• Germany Anchors Translational Medicine Efforts with New Spending Plan and Centers
  Country hopes framework will augment alliances among its institutes as well as assuage industry drug pricing concerns.
  
• 2011’s Five Biggest Biopharma Acquisitions Provide Clues for What’s Ahead
  Purchase of biotech giant Genzyme by Sanofi for $20.1 billion topped the list.
  
• Russia Establishes Clinical Trial Hub
  Cost and speed play big roles in the country’s increased presence in the market.
  
• 10 Best U.S. Regions to Secure a Biotech Job
  GEN shows you where careers are made.
  
• DuBiotech: The Silicon Valley of Biotechnology
  The Dubai Biotechnology & Research Park is open for business and aiming to catch the eye of biotech companies.
  
• No Passage to India
  Private investment dearth clouds the future of the subcontinent’s fast-growing biopharma industry.
  
• Stockholm-Uppsala Region Ups the Ante
  The region bets big in the quest for international renown.
  
• Poland Invests in Biotech Infrastructure
  Will it be enough for the industry to succeed?